SunTrust Reiterates “Neutral” Rating for NCI (NCIT)
NCI (NASDAQ:NCIT)‘s stock had its “neutral” rating restated by analysts at SunTrust in a research report issued to clients and investors on Thursday. They currently have a $10.00 price objective on the stock, down from their previous price objective of $11.00. SunTrust’s target price indicates a potential upside of 11.36% from the stock’s previous close.
Shares of NCI (NASDAQ:NCIT) traded up 5.77% on Thursday, hitting $8.98. The stock had a trading volume of 33,106 shares. NCI has a one year low of $4.75 and a one year high of $13.12. The stock’s 50-day moving average is $9.14 and its 200-day moving average is $9.53. The company has a market cap of $116.3 million and a price-to-earnings ratio of 15.81.
NCI (NASDAQ:NCIT) last released its earnings data on Wednesday, July 30th. The company reported $0.18 earnings per share for the quarter, beating the analysts’ consensus estimate of $0.14 by $0.04. The company had revenue of $77.80 million for the quarter, compared to the consensus estimate of $78.04 million. During the same quarter last year, the company posted $0.14 earnings per share. NCI’s revenue was down 6.3% compared to the same quarter last year. Analysts expect that NCI will post $0.52 EPS for the current fiscal year.
NCI, Inc (NASDAQ:NCIT) a provider of enterprise services and solutions to Defense, Intelligence, Healthcare, and Civilian Government agencies.
Get Analysts' Upgrades and Downgrades via Email - Stay on top of analysts' coverage with Analyst Ratings Network's FREE daily email newsletter that provides a concise list of analysts' upgrades and downgrades. Click here to register now.